-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $21

Benzinga·08/31/2026 11:50:02
Listen to the news
Baird analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and raises the price target from $20 to $21.